Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
CD21 positive B cell: A novel target for treatment of multiple sclerosis.
Seronegative NMO: A sensitive AQP4 antibody test clarifies clinical features and next challenges.
Association of innate immune activation with latent Epstein-Barr virus in active MS lesions.
African ancestry is a predictor factor to secondary progression in clinical course of multiple sclerosis.
The Neurite Outgrowth Inhibitory Nogo-A-Δ20 Region Is an Intrinsically Disordered Segment Harbouring Three Stretches with Helical Propensity.
Safety and efficacy of reduced fingolimod dosage treatment.
Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways.
Culturing microglia from the neonatal and adult central nervous system.
Multicentre absolute myelin water content mapping: Development of a whole brain atlas and application to low-grade multiple sclerosis.
Care ethics for guiding the process of multiple sclerosis diagnosis.
Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.
Gait kinematics of people with Multiple Sclerosis and the acute application of Functional Electrical Stimulation.
Rehabilitation interventions for the management of multiple sclerosis relapse: a short scoping review.
Treatment of relapsing-remitting multiple sclerosis: current and future algorithms.
CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4.
Possible Role of Staphylococcal Enterotoxin B in the Pathogenesis of Autoimmune Diseases.
Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis.
Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormality.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Activated Human CD4+CD45RO+ Memory T-Cells Indirectly Inhibit NLRP3 Inflammasome Activation through Downregulation of P2X7R Signalling.
Diffusion Tensor Analysis of Pediatric Multiple Sclerosis and Clinically Isolated Syndromes.
JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients.
The health promotion work of the district nurse: interpreting its embeddedness.
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.
Multiple Sclerosis (MS) as a demyelinating disease: a review on neurosurgical approaches.
Pages
« first
‹ previous
…
435
436
437
438
439
440
441
442
443
…
next ›
last »